Reproductive Endocrinology and Assisted Reproductive Technologies
Clinical research in women undergoing controlled ovarian stimulation, in vitro fertilisation, and intracytoplasmic sperm injection focuses on improving ovarian response and treatment support within fertility care.
- Controlled ovarian stimulation
- IVF and ICSI cycles
- Gonadotropin-based fertility treatment
The fertility portfolio also includes investigation of treatment combinations used in assisted reproductive technologies and related endocrine support.
Male Fertility and Idiopathic Infertility
Research activities extend to men with unexplained impairment of semen quality, with interest in how fertility-directed treatment may influence the chance of conception in partners.
- Idiopathic male infertility
- Oligoasthenozoospermia
- Spontaneous pregnancy outcomes
This area reflects a broader focus on reproductive medicine for both male and female infertility.
Non-Muscle-Invasive Bladder Cancer
The sponsor supports oncology research in non-muscle-invasive bladder cancer, including disease settings with recurrence risk, carcinoma in situ, and papillary disease.
- High-risk BCG-unresponsive NMIBC
- Intermediate-risk NMIBC
- Bladder cancer recurrence and progression
There is also interest in treatment approaches for patients after local bladder tumour resection and in disease control where standard intravesical options have limited benefit.
Upper Tract Urothelial Carcinoma
Uro-oncology research includes low-grade upper tract urothelial carcinoma, with attention to disease management in the renal pelvis and related urinary tract sites.
- LG-UTUC
- Renal pelvis administration
- Urothelial cancer control
This area complements the sponsor’s broader interest in urothelial malignancies affecting the bladder and upper urinary tract.
Inflammatory Gastrointestinal Disease
The sponsor also funds research in inflammatory gastrointestinal disease, indicating therapeutic interest beyond reproductive and uro-oncology settings.
- Gastrointestinal inflammation
- Chronic intestinal disease
- Digestive tract inflammation
This area adds a gastroenterology dimension to the company’s clinical research portfolio.
